Sri Ranganayaki Madabhushi
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)AstraZeneca (Poland)(PL)
Publications by Year
Research Areas
Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability, RNA Interference and Gene Delivery, Platelet Disorders and Treatments, Extracellular vesicles in disease
Most-Cited Works
- → von Willebrand factor (VWF) propeptide binding to VWF D′D3 domain attenuates platelet activation and adhesion(2012)49 cited
- → Platelet GpIbα Binding to von Willebrand Factor Under Fluid Shear: Contributions of the D'D3‐Domain, A1‐Domain Flanking Peptide and O‐Linked Glycans(2014)41 cited
- → Quantitative assessment of environmental impact of biologics manufacturing using process mass intensity analysis(2018)37 cited
- → Comparison of process mass intensity (PMI) of continuous and batch manufacturing processes for biologics(2022)27 cited
- → Understanding the effect of increased cell specific productivity on galactosylation of monoclonal antibodies produced using Chinese hamster ovary cells(2021)23 cited
- → Epigenetic profile of the euchromatic region of human Y chromosome(2011)21 cited
- → diaPASEF Enables High-Throughput Proteomic Analysis of Host Cell Proteins for Biopharmaceutical Process Development(2024)14 cited
- → Disulfide trapping of protein complexes on the yeast surface(2009)14 cited
- → Green metrics for biologics(2022)7 cited
- → An innovative strategy to recycle permeate in biologics continuous manufacturing process to improve material efficiency and sustainability(2022)7 cited